# US 2003/0079253 A1 · Immunoglobulin binding protein arrays in eukaryotic cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0079253 A1
- Document ID: US20030079253A1
- Status: Published application
- Kind: A1
- Application number: 09/563,222
- Filed: 2000-05-02
- Published: 2003-04-24
- Earliest claimed: 2000-05-02
- Assignees: Epicyte Pharmaceutical, Inc.
- Inventors: Andrew C. Hiatt; Mich B. Hein
- Web page: https://patentgrep.com/patent/US20030079253A1

## CPC

- C07K 16/1282: Clostridium (G)
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C12N 15/8258: {for the production of oral vaccines (antigens) or immunoglobulins}
- C07K 2317/13: isolated from plants
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Arrays of immunoglobulin binding proteins in plants or plant cells are provided. Such arrays comprise plants or plant cells transformed with polynucleotides encoding multiple different immunoglobulin binding proteins, or polypeptide components thereof. Methods are further provided for genetic segregation of the transformation events such that each transformant in an array is capable of producing progeny capable of expressing one or more immunoglobulin binding proteins, including multi-subunit proteins.

## Claims

### Claim 1

A method for preparing an immunoglobulin binding protein array in plant cells, comprising the steps of:
(a) transforming a population of plant cells with a library of at least two different polynucleotides encoding different immunoglobulin binding protein (IgBP) polypeptides that:
(i) specifically bind to a ligand with a KD<10−6 moles/liter; or
(ii) form one or more disulfide bonds with one or more polypeptides in the transfected cell, to generate a binding protein that specifically binds to a ligand with a KD<10−6 moles/liter;
wherein the IgBP polypeptides (i) comprise four framework regions alternating with three complementarity determining regions and (ii) comprise at least one peptide sequence having at least 75% sequence identity to a framework region of a native IgM, IgG, IgA, IgD, IgE, IgY, kappa or lambda immunoglobulin molecule; and wherein the IgBP polypeptides are not detectably expressed by the plant cells prior to transformation; and
(b) selecting transformed plant cells, and therefrom preparing an IgBP array in plant cells.

### Claim 2 (depends on 1)

A method according to claim 1, wherein each IgBP polypeptide is a functional IgBP.

### Claim 3 (depends on 1)

A method according to claim 1, wherein each IgBP polypeptide is an IgBP component that, upon disulfide linkage to one or more IgBP components encoded by other polynucleotides in the library, forms a functional IgBP.

### Claim 4 (depends on 1)

A method according to claim 1, further comprising the step of:
(c) growing the transformed plant cells on a growth medium that supports replication of the plant cells, such that functional IgBPs are assembled by the plant cells.

### Claim 5 (depends on 1)

A method according to claim 1, further comprising the steps of:
(c) growing the transformed plant cells on a growth medium to form plants; and
(d) sexually crossing the plants with themselves or other plants to generate progeny, such that the progeny comprise polynucleotides encoding IgBP components sufficient to form a functional IgBP.

### Claim 6 (depends on 5)

A method according to claim 5, wherein the progeny are seeds.

### Claim 7 (depends on 5)

A method according to claim 5, wherein the progeny are plants or plant cells that assemble functional IgBPs.

### Claim 8 (depends on 1)

A method according to claim 1, wherein the library comprises at least 10 different polynucleotides.

### Claim 9 (depends on 1)

A method according to claim 1, wherein the library comprises at least 100 different polynucleotides.

### Claim 10 (depends on 1)

A method according to claim 1, wherein the library comprises at least 1000 different polynucleotides.

### Claim 11 (depends on 1)

A method according to claim 1, wherein the library comprises at least 10,000 different polynucleotides.

### Claim 12 (depends on 3)

A method according to claim 3, wherein the components comprise one or more portions of immunoglobulin molecules selected from the group consisting of heavy chains and fragments thereof, light chains and fragments thereof, J chains and secretory components.

### Claim 13 (depends on 1)

A method according to claim 1, wherein the polypeptides retain at least 95% amino acid identity to a framework region of a native IgM, IgG, IgA, IgD, IgE, IgY, kappa or lambda immunoglobulin molecule.

### Claim 14 (depends on 1)

A method according to claim 1, wherein the framework regions are human.

### Claim 15 (depends on 1)

A method according to claim 1, wherein the framework regions are murine.

### Claim 16 (depends on 1)

A method according to claim 1, wherein the step of transforming is performed via Agrobacterium-mediated transformation, chemically-induced DNA uptake, electroporation, solid particle intrusion, biolistics, microinjection, macroinjection, lipofection or viral infection.

### Claim 17 (depends on 1)

A method according to claim 1, wherein the IgBP polypeptides are secreted from the plant cells.

### Claim 18 (depends on 1)

A method according to claim 1, wherein the plant cells are dicotyledonous plant cells.

### Claim 19 (depends on 18)

A method according to claim 18, wherein the plant cells are tobacco or Arabidopsis plant cells.

### Claim 20 (depends on 1)

A method according to claim 1, wherein the plant cells are monocotyledonous plant cells.

### Claim 21 (depends on 20)

A method according to claim 20, wherein the plant cells are corn, Lemna or rice plant cells.

### Claim 22 (depends on 1)

A method according to claim 1, wherein the plant cells are lower plant cells.

### Claim 23 (depends on 22)

A method according to claim 22, wherein the plant cells are green algae cells.

### Claim 24 (depends on 23)

A method according to claim 23, wherein the plant cells are Chlamydomonas rheinhardtii.

### Claim 25

A method for preparing a heavy chain binding protein array in eukaryotic cells, comprising the steps of:
(a) transforming a population of eukaryotic cells with a library of at least two different polynucleotides, wherein each polynucleotide encodes a different heavy chain binding protein (CHBP) polypeptide that:
(i) comprises an amino acid sequence that is at least 75% identical to a constant region tailpiece of a mu or alpha chain of a native immunoglobulin heavy chain;
(ii) comprises multiple combining sites, wherein all of the combining sites satisfy the same one of the following requirements:
(1) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin light chain variable region; or
(2) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin heavy chain variable region; and
(iii) either (1) specifically binds to a ligand with a KD<10−6 moles/liter; or (2) forms one or more disulfide bonds with one or more polypeptides in the transfected cell, to generate a CHBP that specifically binds to a ligand with a KD<10−6 moles/liter; and
(b) growing the transformed cells on a medium that permits assembly of CHBPS, wherein each CHBP comprises at least four combining sites;
and therefrom preparing a CHBP array in eukaryotic cells.

### Claim 26 (depends on 25)

A method according to claim 25, wherein the polynucleotides encode immunoglobulin alpha or mu chains.

### Claim 27 (depends on 25)

A method according to claim 25, wherein the cells are further transformed with one or more polynucleotides encoding polypeptides having sequences that are at least 75% identical to a sequence of an immunoglobulin J chain.

### Claim 28 (depends on 25)

A method according to claim 25, wherein each CHBP is assembled from four alpha chains and one J chain.

### Claim 29 (depends on 25)

A method according to claim 25, wherein each CHBP is assembled from twelve mu chains.

### Claim 30 (depends on 25)

A method according to claim 25, wherein each CHBP is assembled from ten mu chain and at least one J chain.

### Claim 31 (depends on 25)

A method according to claim 25, wherein the CHBPs or components thereof further comprise one or more portions of immunoglobulin molecules selected from the group consisting of J chains, secretory components and light chain constant regions.

### Claim 32 (depends on 25)

A method according to claim 25, wherein the cells are plant cells.

### Claim 33 (depends on 25)

A method according to claim 25, wherein the cells are insect cells.

### Claim 34 (depends on 25)

A method according to claim 25, wherein the cells are mammalian cells.

### Claim 35

A method for preparing a plant CHBP array, comprising the steps of:
(a) transforming a population of plant cells with a library of at least two different polynucleotides, wherein each polynucleotide encodes a different CHBP component that forms one or more disulfide bonds with one or more polypeptides in the transformed cell to generate a CHBP that specifically binds to a ligand with a KD<10−6 moles/liter, wherein each component:
(i) comprises an amino acid sequence that is at least 75% identical to a constant region tailpiece of a mu or alpha chain of a native immunoglobulin heavy chain; and
(ii) comprises multiple combining sites, wherein all of the combining sites satisfy the same one of the following requirements:
(1) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin light chain variable region; or
(2) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin heavy chain variable region;
(b) growing the transformed plant cells on a growth medium to form plants; and
(c) sexually crossing the plants to generate progeny, such that the progeny comprise polynucleotides encoding CHBP components sufficient to form a functional CHBP that comprises at least four combining sites;
and therefrom preparing a plant CHBP array.

### Claim 36 (depends on 35)

A method according to claim 35, wherein the progeny are seeds.

### Claim 37 (depends on 35)

A method according to claim 35, wherein the progeny are plants or plant cells that assemble functional CHBPS.

### Claim 38 (depends on 25, 35)

A method according to claim 25 or claim 35, wherein the library comprises at least 10 different polynucleotides.

### Claim 39 (depends on 25, 35)

A method according to claim 25 or claim 35, wherein the library comprises at least 100 different polynucleotides.

### Claim 40 (depends on 25, 35)

A method according to claim 25 or claim 35, wherein the library comprises at least 1000 different polynucleotides.

### Claim 41 (depends on 25, 35)

A method according to claim 25 or claim 35, wherein the library comprises at least 10,000 different polynucleotides.

### Claim 42 (depends on 25, 35)

A method according to claim 25 or claim 35, wherein the polynucleotides encode polypeptides that retain at least 95% amino acid identity to a contant region tailpiece of a mu or alpha chain of a native immunoglobulin heavy chain.

### Claim 43 (depends on 25, 35)

A method according to claim 25 or claim 35, wherein the step of transforming is performed via Agrobacterium-mediated transformation, chemically-induced DNA uptake, electroporation, solid particle intrusion, biolistics, microinjection, macroinjection, lipofection or viral infection.

### Claim 44 (depends on 25, 35)

A method according to claim 25 or claim 35, wherein the binding proteins accumulate in an intracellular compartment of the cells.

### Claim 45 (depends on 25, 35)

A method according to claim 25 or claim 35, wherein the binding proteins are secreted from the cells.

### Claim 46 (depends on 32, 35)

A method according to claim 32 or claim 35, wherein the plant cells are dicotyledonous plant cells.

### Claim 47 (depends on 46)

A method according to claim 46, wherein the plant cells are tobacco or Arabidopsis plant cells.

### Claim 48 (depends on 32, 35)

A method according to claim 32 or claim 35, wherein the plant cells are monocotyledonous plant cells.

### Claim 49 (depends on 48)

A method according to claim 48, wherein the plant cells are corn, Lemna or rice plant cells.

### Claim 50 (depends on 32, 35)

A method according to claim 32 or claim 35, wherein the plant cells are lower plant cells.

### Claim 51 (depends on 50)

A method according to claim 50, wherein the plant cells are green algae cells.

### Claim 52 (depends on 51)

A method according to claim 51, wherein the plant cells are Chlamydomonas rheinhardtii.

### Claim 53

A CHBP array in eukaryotic cells, comprising at least two eukaryotic cells that are each transformed with a different polynucleotide encoding at least one CHBP polypeptide that:
(a) comprises an amino acid sequence that is at least 75% identical to a constant region tailpiece of a mu or alpha chain of a native immunoglobulin heavy chain;
(b) comprises multiple combining sites, wherein all of the combining sites satisfy the same one of the following requirements:
(i) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin light chain variable region; or
(ii) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin heavy chain variable region; and
(c) either (i) specifically binds to a ligand with a KD<10−6 moles/liter; or (ii) forms one or more covalent bonds with one or more polypeptides in the transfected cell, to generate a CHBP that specifically binds to a ligand with a KD<10−6 moles/liter; and
(d) differs in amino acid sequence from other CHBPs in the array;
wherein the cells assemble CHBPs comprising at least four combining sites.

### Claim 54 (depends on 53)

A binding protein array according to claim 53, wherein the polynucleotides encode polypeptide components of immunoglobulin molecules independently selected from the group consisting of heavy chains and fragments thereof, light chains and fragments thereof, J chains and secretory components.

### Claim 55 (depends on 53)

A binding protein array according to claim 53, wherein the cells are plant cells.

### Claim 56 (depends on 53)

A binding protein array according to claim 53, wherein the cells are insect cells.

### Claim 57 (depends on 53)

A binding protein array according to claim 53, wherein the cells are mammalian cells.

### Claim 58 (depends on 55)

A binding protein array according to claim 55, wherein the plant cells are selected from the group consisting of corn, rice, Lemna, tobacco and Chlamydomonas.

### Claim 59 (depends on 53)

A binding protein array according to claim 53, wherein at least different binding proteins are assembled by the cells in the array.

### Claim 60 (depends on 53)

A binding protein array according to claim 53, wherein at least 100 different binding proteins are assembled by the cells in the array.

### Claim 61 (depends on 53)

A binding protein array according to claim 53, wherein at least 100 different binding proteins are assembled by the cells in the array.

### Claim 62 (depends on 53)

A binding protein array according to claim 53, wherein at least 10,000 different binding proteins are assembled by plant cells in the array.

### Claim 63 (depends on 53)

A binding protein array according to claim 53, wherein each cell within the array is transfected with at least two different polynucleotides, each encoding a different CHBP component, such that each cell assembles a functional CHBP comprising the CHBP components.

### Claim 64

A composition comprising an array of encapsulated CHBPS, wherein each CHBP:
(a) comprises an amino acid sequence that is at least 75% identical to a constant region tailpiece of a mu or alpha chain of a native immunoglobulin heavy chain;
(b) comprises at least four combining sites, wherein all of the combining sites satisfy the same one of the following requirements:
(i) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin light chain variable region; or
(ii) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin heavy chain variable region; and
(c) either (i) specifically binds to a ligand with a KD<10−6 moles/liter; or (ii) forms one or more covalent bonds with one or more polypeptides in a cell, to generate a CHBP that specifically binds to a ligand with a KD<10−6 moles/liter; and
(d) differs in amino acid sequence from other CHBPs in the array.

### Claim 65

A method for preparing a heavy chain binding protein array in eukaryotic cells, comprising the steps of:
(a) exposing multiple copies of a polynucleotide encoding a native heavy chain to a mutagen, such that random or site-directed mutagenesis of the polynucleotide occurs, resulting in a library of heavy chain variants;
(b) transforming a population of eukaryotic cells with the library of heavy chain variants; and
(c) growing the transformed cells on a medium that permits assembly of CHBPS, wherein each CHBP comprises at least four combining sites;
and therefrom preparing a CHBP array in eukaryotic cells.

### Claim 66

A CHBP that:
(a) comprises an amino acid sequence that is at least 75% identical to a constant region tailpiece of a mu or alpha chain of a native immunoglobulin heavy chain;
(b) comprises at least four combining sites, wherein all of the combining sites satisfy the same one of the following requirements:
(i) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin light chain variable region; or
(ii) at least 75% identity to a 25 consecutive amino acid portion of an immunoglobulin heavy chain variable region; and
(c) either (i) specifically binds to a ligand with a KD<10−6 moles/liter; or (ii) forms one or more covalent bonds with one or more polypeptides in a cell, to generate a CHBP that specifically binds to a ligand with a KD<10−6 moles/liter.
